All Stories

  1. Long-Term Prognostic Value in Nuclear Cardiology: Expert Scoring Combined with Automated Measurements vs. Angiographic Score
  2. Long-Term Prognostic Value of Automated Measurements in Nuclear Cardiology: Comparisons with Expert Scoring
  3. Investigating the genetic characteristics of CAD: Is there a role for myocardial perfusion imaging techniques?
  4. Automated Analysis vs. Expert Reading in Nuclear Cardiology: Correlations with the Angiographic Score
  5. Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis
  6. Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
  7. Correlation of Neuropsychiatric Symptoms in Dementia with Brain Perfusion: A 99mTc-SPECT-HMPAO Study with Brodmann Areas Analysis
  8. α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism
  9. From courage to ischaemia: is still there a role for myocardial perfusion imaging (MPI) in stable coronary artery disease?
  10. Eating Disorders in Frontotemporal Dementia and Alzheimer’s Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis
  11. Fahr’s syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases
  12. COVID-19 crisis: will online learning have negative consequences to our students?
  13. COVID‐19 and nuclear cardiology: Introducing the “forward” virtual visit
  14. Differences of apathy perfusion correlates between Alzheimer’s disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis
  15. In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?
  16. A second wave of COVID-19 infections should not lead to a new disruption of services in nuclear cardiology
  17. Premature CAD: Conventional Screening and Diagnostic Strategies May Not Capture the “Whole Picture”
  18. Exercise stress testing: Time to restart in nuclear cardiology?
  19. SLC2A3 rs12842 polymorphism and risk for Alzheimer’s disease
  20. Low-dose radiation cancer risk hypothesis may lead to ‘radiophobia’-driven imaging avoidance?
  21. Pet tracers for vulnerable plaque imaging
  22. Novel approaches for the management of coronary artery disease
  23. Impact of renin–angiotensin–aldosterone system polymorphisms on myocardial perfusion: Correlations with myocardial single photon emission computed tomography-derived parameters
  24. Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
  25. Detection of extramedullary hematopoietic tissue in a patient with beta-thalassemia major on Tc99m-sestamibi parathyroid scintigraphy
  26. Obstrucción de la vena cava superior por seminoma testicular con metástasis en el mediastino. Imagen de vías colaterales durante la gammagrafía por hemorragia intestinal con hematíes marcados con 99mTc
  27. SPECT and PET imaging in Alzheimer’s disease
  28. Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA
  29. 18F-fluorothymidine PET imaging in gliomas: an update
  30. SPECT and PET in ischemic heart failure
  31. Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report
  32. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease
  33. Radioisotopic vs Non-Radioisotopic Methods for Myocardial Viability Identification
  34. Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages
  35. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer’s Disease
  36. Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
  37. The Emerging Roles of Adiponectin in Female Reproductive System-Associated Disorders and Pregnancy
  38. Radiolabeling approaches of nanoparticles with99mTc
  39. Metabolism-Related Cytokine and Hormone Levels in the Serum of Patients with Myelodysplastic Syndromes
  40. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer’s disease from frontotemporal degeneration syndromes
  41. Ghrelin
  42. Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
  43. Incremental prognostic value of 99mTc-tetrofosmin early poststress pulmonary uptake. Determination of the optimal cut-off value
  44. SPECT and PET Imaging of Meningiomas
  45. Clinical Significance of Tetrofosm in Extracardiac Uptake During Myocardial Perfusion Imaging
  46. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?
  47. Sequence Variations in the FII , FV , F13A1 , FGB and PAI-1 Genes are Associated with Differences...
  48. Current and potential roles of ghrelin in clinical practice
  49. Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance?
  50. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome
  51. Alzheimers Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  52. Alzheimer's Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
  53. Myocardial Perfusion SPECT Imaging in Patients after Percutaneous Coronary Intervention
  54. Darwinian molecular imaging in nuclear cardiology
  55. Long-term prognostic value of early poststress 99mTc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging
  56. Impact of ACE and ApoE polymorphisms on myocardial perfusion: correlation with myocardial single photon emission computed tomographic imaging
  57. On the accuracy of a mutual information algorithm for PET-MR image registration
  58. Evaluation of brain perfusion in specific Brodmann areas in Frontotemporal dementia and Alzheimer disease using automated 3-D voxel based analysis
  59. P065 Profile of metabolism-related cytokines in myelodysplastic syndromes
  60. Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus
  61. The Role of Nuclear Medicine in Vascular Dementia
  62. SPECT Imaging and Cerebrovascular Disease
  63. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  64. Incremental prognostic value of 99mTc-tetrofosmin myocardial SPECT after percutaneous coronary intervention
  65. Heart-rate recovery as a clinical marker of cardiovascular autonomic dysfunction in diabetic patients
  66. Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging
  67. Long-Term Prognostic Value of Tc-99m Tetrofosmin Myocardial Gated-SPECT Imaging in Asymptomatic Patients After Percutaneous Coronary Intervention
  68. Radiopharmaceuticals in Neurological and Psychiatric Disorders
  69. Myocardial Perfusion SPECT Imaging in Patients after Coronary Revascularization
  70. SPECT Imaging and Cerebrovascular Disease
  71. 99mTechnetium-ciprofloxacin Scintigraphy for the Evaluation of Spinal Infections
  72. Multiple Meningiomas
  73. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography
  74. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer
  75. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer
  76. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI